By Maggie Fick LONDON (Reuters) -Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff wars, hoping to avert price spikes on ...
The Brevard-based doctor and former congressman said: "The concern of many people is that big Pharma was behind this, which ...
Pharma brands that fail to evolve risk losing relevance in a world where patients demand more control, transparency, and ...
ET Now on MSN8h
Dividend Rs 55 by pharma company; record date in AprilA pharma company has declared a final dividend of Rs 55 on each stock. The company has also fixed the record date for ...
Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global ...
In addition to a continued focus on growing drug pipelines, and the increasing use of artificial intelligence (AI) and data ...
Vincerx Pharma shares jumped Tuesday morning after the company said that it has entered into an agreement to combine with privately held AI computing infrastructure company Global Digital Holdings.
Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...
Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has entered into a non-binding letter of intent ("LOI") with Global Digital Holdings ...
Driven by innovation, research, and a deep commitment to social responsibility, Pharmalat has grown from a small, family-run ...
DUBLIN, IE / ACCESS Newswire / March 18, 2025 / Nemysis is pleased to announce signing of a Subscription Agreement (the "Agreement") under which Avia Pharma AB has invested in the capital of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback